FDA Responds To Coronavirus By Getting Out First Emergency-Use Novel Coronavirus Diagnostic

The US agency on 4 February issued its first Emergency Use Authorization of a 2019-novel coronavirus test by enabling emergency use of the Centers for Disease Control and Prevention’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel. The move will allow use of the test at any CDC-qualified lab across the US.

Coronavirus disease and flu outbreak or coronaviruses influenza background as dangerous viral strain case as a pandemic medical health risk concept with dangerous cells as a 3D render

More from In Vitro Diagnostics

More from Diagnostics